ConvaTec Group plc ADR (CNVVY)
ConvaTec Group plc ADR is a depositary receipt representing the common stock of ConvaTec Group plc and is traded on OTC Markets. The underlying company develops, manufactures, and sells medical products, services, and technologies used in the management of chronic conditions across Europe, North America, and other international markets. Its portfolio includes advanced wound care products for acute and chronic wounds, ostomy care solutions for people living with a stoma, continence care products and related services, and infusion care solutions such as disposable infusion sets used with diabetes insulin pumps and certain continuous infusion treatments. The company sells through pharmacies, hospitals, and other acute and post-acute healthcare providers, working both directly and through distributors and wholesalers. Founded in 1978, Convatec is headquartered in London, United Kingdom.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Payment Date | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CNVV.Y
|
$13.21
|
14.4% Upside
|
Fair
|
$13.80
|
19.5% Upside
|
Undervalued
|
Good
|
October 15, 2026
|
2.1%
|
November 18, 2026
|
45.2x
|
3.9x
|
2.2x
|
5.612 B
|
7.26 B
|
23.7%
|
99.8%
|
5.5
|
115.3%
|
174.2%
|
